
Ziqiao Wang
· Assistant Professor of Genome SciencesUniversity of Virginia · Genome Sciences
Active 2001–2024
About
Ziqiao Wang is an Assistant Professor in the Department of Genome Sciences at the University of Virginia School of Medicine. He holds a PhD in Biostatistics from The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences and completed postdoctoral training in Biostatistics at Johns Hopkins University. His research focuses on how genetics, genomics, and environmental factors together drive the development of human diseases. He specializes in statistical methodology developments, data analysis, and theoretical investigations, utilizing large-scale datasets from biobanks and epidemiological studies that include molecular genetic and genomic data, along with human behavioral and lifestyle factors. His work includes developing novel statistical methods to jointly model gene-environment correlations and interactions using polygenic scores in case-control studies, with applications in datasets such as the UK Biobank. He has also developed methods for estimating risk parameters of polygenic scores in family-based studies to understand genetic direct, indirect, and gene-environment interactions, with applications in autism research through the SPARK Consortium. Additionally, Wang investigates integrative omics using individual-level and summary statistics to understand disease mechanisms and improve disease risk predictions, employing machine learning algorithms to enhance the statistical power of large-scale association studies. His research extends to identifying DNA methylation biomarkers associated with pancreatic cancer and discovering potential pre-diagnostic plasma proteomic markers for multiple solid cancers within prospective cohort studies.
Research topics
- Biology
- Genetics
- Cell biology
- Computational biology
- Chemistry
- Cancer research
- Molecular biology
Selected publications
UTX condensation underlies its tumour-suppressive activity
Nature · 2021 · 198 citations
- Cell biology
- Chemistry
- Biology
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
Genome biology · 2020 · 125 citations
- Biology
- Genetics
- Computational biology
BACKGROUND: The three-dimensional genome organization is critical for gene regulation and can malfunction in diseases like cancer. As a key regulator of genome organization, CCCTC-binding factor (CTCF) has been characterized as a DNA-binding protein with important functions in maintaining the topological structure of chromatin and inducing DNA looping. Among the prolific binding sites in the genome, several events with altered CTCF occupancy have been reported as associated with effects in physiology or disease. However, hitherto there is no comprehensive survey of genome-wide CTCF binding patterns across different human cancers. RESULTS: To dissect functions of CTCF binding, we systematically analyze over 700 CTCF ChIP-seq profiles across human tissues and cancers and identify cancer-specific CTCF binding patterns in six cancer types. We show that cancer-specific lost and gained CTCF binding events are associated with altered chromatin interactions, partially with DNA methylation changes, and rarely with sequence mutations. While lost bindings primarily occur near gene promoters, most gained CTCF binding events exhibit enhancer activities and are induced by oncogenic transcription factors. We validate these findings in T cell acute lymphoblastic leukemia cell lines and patient samples and show that oncogenic NOTCH1 induces specific CTCF binding and they cooperatively activate expression of target genes, indicating transcriptional condensation phenomena. CONCLUSIONS: Specific CTCF binding events occur in human cancers. Cancer-specific CTCF binding can be induced by other transcription factors to regulate oncogenic gene expression. Our results substantiate CTCF binding alteration as a functional epigenomic signature of cancer.
iScience · 2020 · 27 citations
- Biology
- Cell biology
- Molecular biology
. Here we report that polyadenylation of H3.1 mRNA increases H3.1 protein, resulting in displacement of histone variant H3.3 at active promoters, enhancers, and insulator regions, leading to transcriptional deregulation, G2/M cell-cycle arrest, chromosome aneuploidy, and aberrations. In support of these observations, knocking down the expression of H3.3 induced cell transformation, whereas ectopic expression of H3.3 attenuated arsenic-induced cell transformation. Notably, arsenic exposure also resulted in displacement of H3.3 from active promoters, enhancers, and insulator regions. These data suggest that H3.3 displacement might be central to carcinogenesis caused by polyadenylation of H3.1 mRNA upon arsenic exposure. Our findings illustrate the importance of proper histone stoichiometry in maintaining genome integrity.
Frequent coauthors
- 66 shared
Chongzhi Zang
University of Virginia
- 17 shared
Zhangli Su
University of Alabama at Birmingham
- 17 shared
Yoshiyuki Shibata
Kure Medical Center
- 17 shared
Etsuko Shibata
University of Alabama at Birmingham
- 16 shared
Anindya Dutta
University of Alabama at Birmingham
- 14 shared
Richard D. Minshall
University of Illinois Urbana-Champaign
- 14 shared
Chinnaswamy Tiruppathì
University of Illinois Chicago
- 14 shared
Asrar B. Malik
University of Illinois Chicago
Education
- 2021
PhD, Quantitative Sciences-Biostatistics
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences
- 2015
BS, Mathematics and Statistics
Stony Brook University
- 2013
BS, Mathematics
Nanjing University
Similar researchers at University of Virginia
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Ziqiao Wang
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup